Last reviewed · How we verify

Miebo — Competitive Intelligence Brief

Miebo (PERFLUOROHEXYLOCTANE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Semifluorinated Alkane [EPC]. Area: Ophthalmology.

marketed Semifluorinated Alkane [EPC] Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Miebo (PERFLUOROHEXYLOCTANE) — Bausch Health. Miebo works by mimicking the natural oils in the eyes to help maintain moisture.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Miebo TARGET PERFLUOROHEXYLOCTANE Bausch Health marketed Semifluorinated Alkane [EPC] 2023-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Semifluorinated Alkane [EPC] class)

  1. Bausch Health · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Miebo — Competitive Intelligence Brief. https://druglandscape.com/ci/perfluorohexyloctane. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: